(Q43150813)

14 November 2017

Immunoproteasome beta subunit 10 is increased in chronic antibody-mediated rejection (English)

1 reference

14 November 2017

1 reference

5

1 reference

14 November 2017

18

Jean-Paul Soulillou

1 reference

14 November 2017

Joanna Ashton-Chess

1

1 reference

14 November 2017

Hoa Le Mai

2

1 reference

14 November 2017

Vojislav Jovanovic

3

1 reference

14 November 2017

Karine Renaudin

4

1 reference

14 November 2017

Magali Giral

6

1 reference

14 November 2017

Anne Moreau

7

1 reference

14 November 2017

Emilie Dugast

8

1 reference

14 November 2017

Michael Mengel

9

1 reference

14 November 2017

Maud Racapé

10

1 reference

14 November 2017

Richard Danger

11

1 reference

14 November 2017

Claire Usal

12

1 reference

14 November 2017

Helga Smit

13

1 reference

14 November 2017

Marina Guillet

14

1 reference

14 November 2017

Wilfried Gwinner

15

1 reference

14 November 2017

Ludmilla Le Berre

16

1 reference

14 November 2017

Jacques Dantal

17

1 reference

14 November 2017

Sophie Brouard

19

1 reference

14 November 2017

language of work or name

English

0 references

publication date

24 February 2010

1 reference

14 November 2017

1 reference

14 November 2017

77

1 reference

14 November 2017

10

1 reference

14 November 2017

880-890

1 reference

https://scigraph.springernature.com/pub.10.1038/ki.2010.15

14 November 2017

0 references

cites work

Humoral theory of transplantation

1 reference

https://api.crossref.org/works/10.1038%2FKI.2010.15

7 January 2021

Predicting kidney graft failure by HLA antibodies: a prospective trial.

1 reference

https://api.crossref.org/works/10.1038%2FKI.2010.15

7 January 2021

Predictive value of HLA antibodies and serum creatinine in chronic rejection: results of a 2-year prospective trial

1 reference

https://api.crossref.org/works/10.1038%2FKI.2010.15

7 January 2021

Capillary deposition of complement split product C4d in renal allografts is associated with basement membrane injury in peritubular and glomerular capillaries: a contribution of humoral immunity to chronic allograft rejection

1 reference

https://api.crossref.org/works/10.1038%2FKI.2010.15

7 January 2021

Banff '05 Meeting Report: differential diagnosis of chronic allograft injury and elimination of chronic allograft nephropathy ('CAN')

1 reference

https://api.crossref.org/works/10.1038%2FKI.2010.15

7 January 2021

Post-transplant therapy with high-dose intravenous gammaglobulin: Applications to treatment of antibody-mediated rejection

1 reference

https://api.crossref.org/works/10.1038%2FKI.2010.15

7 January 2021

Addition of plasmapheresis decreases the incidence of acute antibody-mediated rejection in sensitized patients with strong donor-specific antibodies

1 reference

https://api.crossref.org/works/10.1038%2FKI.2010.15

7 January 2021

Rituximab therapy for acute humoral rejection after kidney transplantation

1 reference

https://api.crossref.org/works/10.1038%2FKI.2010.15

7 January 2021

C4d-positive chronic rejection: a frequent entity with a poor outcome.

1 reference

https://api.crossref.org/works/10.1038%2FKI.2010.15

7 January 2021

Endothelial gene expression in kidney transplants with alloantibody indicates antibody-mediated damage despite lack of C4d staining.

1 reference

https://api.crossref.org/works/10.1038%2FKI.2010.15

7 January 2021

Indirect CD4+ TH1 response, antidonor antibodies and diffuse C4d graft deposits in long-term recipients conditioned by donor antigens priming.

1 reference

https://api.crossref.org/works/10.1038%2FKI.2010.15

7 January 2021

Expression profiling on chronically rejected transplant kidneys.

1 reference

https://api.crossref.org/works/10.1038%2FKI.2010.15

7 January 2021

De novo kidney transplantation without use of calcineurin inhibitors preserves renal structure and function at two years.

1 reference

https://api.crossref.org/works/10.1038%2FKI.2010.15

7 January 2021

The MHC class I ligand-generating system: roles of immunoproteasomes and the interferon-gamma-inducible proteasome activator PA28.

1 reference

https://api.crossref.org/works/10.1038%2FKI.2010.15

7 January 2021

Dampening Ab responses using proteasome inhibitors following in vivo B cell activation

1 reference

https://api.crossref.org/works/10.1038%2FKI.2010.15

7 January 2021

Differential processing of class-I-restricted epitopes by the standard proteasome and the immunoproteasome

1 reference

https://api.crossref.org/works/10.1038%2FKI.2010.15

7 January 2021

The proteasome: structure, function, and role in the cell

1 reference

https://api.crossref.org/works/10.1038%2FKI.2010.15

7 January 2021

T cells lacking immunoproteasome subunits MECL-1 and LMP7 hyperproliferate in response to polyclonal mitogens

1 reference

https://api.crossref.org/works/10.1038%2FKI.2010.15

7 January 2021

The proteasome immunosubunit multicatalytic endopeptidase complex-like 1 is a T-cell-intrinsic factor influencing homeostatic expansion

1 reference

https://api.crossref.org/works/10.1038%2FKI.2010.15

7 January 2021

An altered T cell repertoire in MECL-1-deficient mice

1 reference

https://api.crossref.org/works/10.1038%2FKI.2010.15

7 January 2021

Lymphoid neogenesis in chronic rejection: evidence for a local humoral alloimmune response

1 reference

https://api.crossref.org/works/10.1038%2FKI.2010.15

7 January 2021

Antigen-processing machinery in human dendritic cells: up-regulation by maturation and down-regulation by tumor cells

1 reference

https://api.crossref.org/works/10.1038%2FKI.2010.15

7 January 2021

Progressively impaired proteasomal capacity during terminal plasma cell differentiation

1 reference

https://api.crossref.org/works/10.1038%2FKI.2010.15

7 January 2021

Development of the proteasome inhibitor Velcade (Bortezomib).

1 reference

https://api.crossref.org/works/10.1038%2FKI.2010.15

7 January 2021

A proteasome inhibitor effectively prevents mouse heart allograft rejection

1 reference

https://api.crossref.org/works/10.1038%2FKI.2010.15

7 January 2021

Dipeptide boronic acid, a novel proteasome inhibitor, prevents islet-allograft rejection

1 reference

https://api.crossref.org/works/10.1038%2FKI.2010.15

7 January 2021

Proteasome inhibition suppresses essential immune functions of human CD4+ T cells

1 reference

https://api.crossref.org/works/10.1038%2FKI.2010.15

7 January 2021

Proteasome inhibitor bortezomib modulates TLR4-induced dendritic cell activation

1 reference

https://api.crossref.org/works/10.1038%2FKI.2010.15

7 January 2021

Contrasted blood and intragraft toll-like receptor 4 mRNA profiles in operational tolerance versus chronic rejection in kidney transplant recipients

1 reference

https://api.crossref.org/works/10.1038%2FKI.2010.15

7 January 2021

The proteasome inhibitor bortezomib depletes plasma cells and protects mice with lupus-like disease from nephritis

1 reference

https://api.crossref.org/works/10.1038%2FKI.2010.15

7 January 2021

Proteasome inhibition causes apoptosis of normal human plasma cells preventing alloantibody production

1 reference

https://api.crossref.org/works/10.1038%2FKI.2010.15

7 January 2021

Abrogation of anti-HLA antibodies via proteasome inhibition

1 reference

https://api.crossref.org/works/10.1038%2FKI.2010.15

7 January 2021

The Fischer-Lewis model of chronic allograft rejection--a summary

1 reference

https://api.crossref.org/works/10.1038%2FKI.2010.15

7 January 2021

Differential expression of profibrotic and growth factors in chronic allograft nephropathy

1 reference

https://api.crossref.org/works/10.1038%2FKI.2010.15

7 January 2021

Early prognosis of the development of renal chronic allograft rejection by gene expression profiling of human protocol biopsies

1 reference

https://api.crossref.org/works/10.1038%2FKI.2010.15

7 January 2021

Genetics of the blood transfusion effect on heart allografts in rats

1 reference

https://api.crossref.org/works/10.1038%2FKI.2010.15

7 January 2021

New evidence for a role of allograft accommodation in long-term tolerance.

1 reference

https://api.crossref.org/works/10.1038%2FKI.2010.15

7 January 2021

Extrarenal effects on the pathogenesis and relapse of idiopathic nephrotic syndrome in Buffalo/Mna rats

1 reference

https://api.crossref.org/works/10.1038%2FKI.2010.15

7 January 2021

Tribbles-1 as a novel biomarker of chronic antibody-mediated rejection.

1 reference

https://api.crossref.org/works/10.1038%2FKI.2010.15

7 January 2021

C4d deposition and clearance in cardiac transplants correlates with alloantibody levels and rejection in rats

1 reference

https://api.crossref.org/works/10.1038%2FKI.2010.15

7 January 2021

Analysis of Relative Gene Expression Data Using Real-Time Quantitative PCR and the 2−ΔΔCT Method

1 reference

https://api.crossref.org/works/10.1038%2FKI.2010.15

7 January 2021

Identifiers

DOI

10.1038/KI.2010.15

1 reference

14 November 2017

1 reference